For instance, early oxidative stress may primarily induce mitochondrial damage and ferroptosis, subsequently triggering compensatory activation of mitophagy (Gross, 2024)
The volume of cases within this MDL has continued to rise, reflecting widespread reports from users who experienced significant gallbladder-related issues
Semaglutide 2.4 mg (Wegovy) typically produces ~15% weight reduction, liraglutide 3.0 mg (Saxenda) ~8%, and tirzepatide (Zepbound) ~15-21%
You may experience temporary soreness at the injection site or mild flushing
This is why tirzepatide tends to produce greater average weight loss but it also means more variables to manage
If semaglutide (single agonist) is first generation, and tirzepatide and mazdutide (dual agonists) are second generation, then retatrutide (triple agonist) is the beginning of the third generation